Drug – bio-affecting and body treating compositions – Dentifrices – Fluorine or fluorine compound containing
Patent
1983-06-08
1984-03-13
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Dentifrices
Fluorine or fluorine compound containing
424 49, 424 34, A61K 716, A61K 718, A61K 722
Patent
active
044367210
ABSTRACT:
Anti-caries, anti-calculus oral composition, such as dental cream or gel or mouthwash, containing a diamine tetra (methylene phosphonic acid) salt, such as ethylene diamine tetra (methylene polyphosphonic acid) salt, and alkali metal fluoride, such as sodium fluoride. The mole ratio of the tetra (methylene phosphonate) portion to fluoride is at least 1.4:1, thereby providing optimum anti-caries and anti-calculus effects.
REFERENCES:
patent: 4137303 (1979-01-01), Gaffar et al.
patent: 4143128 (1979-03-01), Kim et al.
patent: 4177258 (1979-12-01), Gaffar et al.
patent: 4183915 (1980-01-01), Gaffar et al.
Chem. Abstr. 80:74327k, (1974) of Ger. Offen. 2224516, (12-06-73) (Counterpart of Henkel & CIE British Patent No. 1,394,034.
Chem. Abstr. 92:135445a, (1980), of U.S. 4,177,258, (12-04-79).
Chem. Abstr. 99:64269w, (1983), Calcif. Tissue Int. 35:362-365, (1983), Effects of Editempa on Dental Calculus and Caries Formation in vivo.
Colgate-Palmolive Company
Grill Murray M.
Rose Shep K.
Stone Robert L.
Sylvester Herbert S.
LandOfFree
Oral composition having mole ratio of tetra (methylene phosphona does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral composition having mole ratio of tetra (methylene phosphona, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral composition having mole ratio of tetra (methylene phosphona will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-491738